Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System
- PMID: 27591183
- PMCID: PMC5164844
- DOI: 10.1016/j.amjmed.2016.07.028
Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System
Abstract
Background: Effective colorectal cancer screening depends on timely diagnostic evaluation in patients with abnormal results on fecal immunochemical tests (FITs). Although prior studies suggest low rates of follow-up colonoscopy, there is little information among patients in safety-net health systems and few data characterizing reasons for low follow-up rates. This study aimed to characterize factors contributing to lack of follow-up colonoscopy in a racially diverse and socioeconomically disadvantaged cohort of patients with abnormal results on FIT ("abnormal FIT" for brevity) receiving care in an integrated safety-net health system.
Methods: We performed a retrospective electronic medical record review of patients aged 50-64 years with abnormal FIT at a population-based safety-net health system between January 2010 and July 2013. Review of electronic medical records focused on patients without follow-up colonoscopy to characterize patient-, provider-, and system-level reasons for lack of diagnostic evaluation. We used logistic regression analysis to identify predictors of follow-up colonoscopy within 12 months of abnormal FIT.
Results: Of 1267 patients with abnormal FIT, 536 (42.3%) failed to undergo follow-up colonoscopy within 1 year. Failure was attributable to patient-level factors in 307 (57%) cases, provider factors in 97 (18%) cases, and system factors in 118 (22%) cases. In multivariate analysis, follow-up colonoscopy was less likely among those aged 61-64 years (odds ratio 0.63, 95% confidence interval 0.46-0.87) compared with 50-55 year olds.
Conclusions: Nearly half (42%) of patients with abnormal FIT failed to undergo follow-up colonoscopy within 1 year. Lack of diagnostic evaluation is related to a combination of patient-, provider-, and system-level factors, highlighting the need for multilevel interventions to improve follow-up colonoscopy completion rates.
Keywords: Colonoscopy; Colorectal cancer screening; Fecal immunochemical test; Randomized controlled trial; Safety-net health system.
Copyright © 2016 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Colorectal Cancer Screening, Fecal Immunochemical Tests, and New Oral Anticoagulants.Am J Med. 2017 Feb;130(2):e73. doi: 10.1016/j.amjmed.2016.09.024. Am J Med. 2017. PMID: 28117043 No abstract available.
Similar articles
-
Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.Am J Prev Med. 2019 May;56(5):e143-e152. doi: 10.1016/j.amepre.2019.01.005. Am J Prev Med. 2019. PMID: 31003603 Free PMC article.
-
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.Cancer. 2016 Feb 1;122(3):456-63. doi: 10.1002/cncr.29770. Epub 2015 Nov 4. Cancer. 2016. PMID: 26535565 Free PMC article. Clinical Trial.
-
Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.J Gen Intern Med. 2019 Sep;34(9):1730-1736. doi: 10.1007/s11606-019-05117-0. Epub 2019 Jun 21. J Gen Intern Med. 2019. PMID: 31228053 Free PMC article.
-
Screening for Colorectal Cancer: An Updated Systematic Review [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Oct. Report No.: 08-05-05124-EF-1. PMID: 20722162 Free Books & Documents. Review.
-
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review.Ann Intern Med. 2017 Oct 17;167(8):565-575. doi: 10.7326/M17-1361. Epub 2017 Oct 10. Ann Intern Med. 2017. PMID: 29049756 Free PMC article. Review.
Cited by
-
Optimizing tracking and completion of follow-up colonoscopy after abnormal stool tests at health systems participating in the Centers for Disease Control and Prevention's Colorectal Cancer Control Program.Cancer Causes Control. 2024 Aug 6. doi: 10.1007/s10552-024-01898-w. Online ahead of print. Cancer Causes Control. 2024. PMID: 39107449
-
Colonoscopy Outreach for Rural Communities (CORC): A study protocol of a pragmatic randomized controlled trial of a patient navigation program to improve colonoscopy completion for colorectal cancer screening.Contemp Clin Trials. 2024 Jun;141:107539. doi: 10.1016/j.cct.2024.107539. Epub 2024 Apr 12. Contemp Clin Trials. 2024. PMID: 38615750 Clinical Trial.
-
Engaging primary care physicians is critical in the screening and diagnosis of colorectal cancer at safety-net hospital systems.Surg Open Sci. 2023 Dec 21;17:6-10. doi: 10.1016/j.sopen.2023.12.001. eCollection 2024 Jan. Surg Open Sci. 2023. PMID: 38235211 Free PMC article.
-
Time to Endoscopy or Colonoscopy Among Adults Younger Than 50 Years With Iron-Deficiency Anemia and/or Hematochezia in the VHA.JAMA Netw Open. 2023 Nov 1;6(11):e2341516. doi: 10.1001/jamanetworkopen.2023.41516. JAMA Netw Open. 2023. PMID: 37930701 Free PMC article.
-
Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening.Clin Gastroenterol Hepatol. 2023 Jun;21(6):1667-1669.e2. doi: 10.1016/j.cgh.2022.12.014. Epub 2022 Dec 23. Clin Gastroenterol Hepatol. 2023. PMID: 36566814 Free PMC article. No abstract available.
References
-
- Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–17. - PubMed
-
- Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95. - PubMed
-
- Elmunzer BJ, Singal AG, Sussman JB, Deshpande AR, Sussman DA, Conte ML, Dwamena BA, Rogers MA, Schoenfeld PS, Inadomi JM, Saini SD, Waljee AK. Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointest Endosc. 2015;81:700–709. e3. - PMC - PubMed
-
- Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
